359 related articles for article (PubMed ID: 38395759)
1. Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children's Hospital.
Tariverdi M; Mohammadi H; Hassanzadeh F; Tamaddondar M
BMC Infect Dis; 2024 Feb; 24(1):253. PubMed ID: 38395759
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco).
Ben Houmich T; Tali A; Debbagh F; Lamrani Hanchi A; Soraa N
Int J Immunopathol Pharmacol; 2022; 36():3946320221133697. PubMed ID: 36215392
[TBL] [Abstract][Full Text] [Related]
3. Post-vaccination SARS-CoV-2 IgG spike antibody responses among clinical and non-clinical healthcare workers at a tertiary facility in Kenya.
Mwangi LW; Omuse G; Adam R; Ong'ete G; Matheka C; Mugaine P; Sayed S; Maina D
PLoS One; 2024; 19(4):e0299302. PubMed ID: 38573911
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
[TBL] [Abstract][Full Text] [Related]
5. Post-vaccination SARS-CoV-2 seroprevalence in children aged 3-11 years and the positivity in unvaccinated children: A retrospective, single-center study.
Li J; Ge M; Dai S; Song Q; Liu W; Wang Y; Xu W; Ma L
Front Immunol; 2022; 13():1030238. PubMed ID: 36420275
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Santhosh Kumar M; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Chopra V; Das D; Devi KR; Dwivedi GR; Jain A; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Ramesh T; Rangaraju C; Turuk J; Yadav S; Bhargava B;
PLoS Med; 2021 Dec; 18(12):e1003877. PubMed ID: 34890407
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study.
Maina D; Omuse G; Ong'ete G; Mugaine P; Sayed S; Moloo Z; Shah R; Etyang A; Adam R
PLoS One; 2022; 17(10):e0267619. PubMed ID: 36301926
[TBL] [Abstract][Full Text] [Related]
8. Durability of COVID-19 humoral immunity post infection and different SARS-COV-2 vaccines.
Alroqi F; Barhoumi T; Masuadi E; Nogoud M; Aljedaie M; Abu-Jaffal AS; Bokhamseen M; Saud M; Hakami M; Arabi YM; Nasr A
J Infect Public Health; 2024 Apr; 17(4):704-711. PubMed ID: 38479067
[TBL] [Abstract][Full Text] [Related]
9. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
Özgür D; Tütüncü EE
Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
[TBL] [Abstract][Full Text] [Related]
10. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
Scaggs Huang F
J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up.
Recanatini C; GeurtsvanKessel CH; Pas SD; Broens EM; Maas M; van Mansfeld R; Mutsaers-van Oudheusden AJG; van Rijen M; Schippers EF; Stegeman A; Tami A; Veldkamp KE; Visser H; Voss A; Wegdam-Blans MCA; Wertheim HFL; Wever PC; Koopmans MPG; Kluytmans JAJW; Kluytmans-van den Bergh MFQ;
Antimicrob Resist Infect Control; 2023 Nov; 12(1):137. PubMed ID: 38031155
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
Martin CA; Marshall C; Patel P; Goss C; Jenkins DR; Ellwood C; Barton L; Price A; Brunskill NJ; Khunti K; Pareek M
PLoS Med; 2021 Nov; 18(11):e1003823. PubMed ID: 34739480
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.
Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R
Front Public Health; 2022; 10():832003. PubMed ID: 35400056
[TBL] [Abstract][Full Text] [Related]
14. Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?
Stellini R; Gianello R; Gomarasca W
Infection; 2022 Dec; 50(6):1573-1577. PubMed ID: 35391649
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries.
Goldblatt D; Johnson M; Falup-Pecurariu O; Ivaskeviciene I; Spoulou V; Tamm E; Wagner M; Zar HJ; Bleotu L; Ivaskevicius R; Papadatou I; Jõgi P; Lischka J; Franckling-Smith Z; Isarova D; Grandjean L; Zavadska D
J Hosp Infect; 2021 Apr; 110():60-66. PubMed ID: 33422589
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France.
Decarreaux D; Pouquet M; Souty C; Vilcu AM; Prévot-Monsacre P; Fourié T; Villarroel PMS; Priet S; Blanché H; Sebaoun JM; Deleuze JF; Turbelin C; Werner A; Kochert F; Grosgogeat B; Rabiega P; Laupie J; Abraham N; Guerrisi C; Noël H; Van der Werf S; Carrat F; Hanslik T; Charrel R; De Lamballerie X; Blanchon T; Falchi A
Viruses; 2022 May; 14(5):. PubMed ID: 35632699
[TBL] [Abstract][Full Text] [Related]
17. Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study.
Reusch J; Wagenhäuser I; Gabel A; Eggestein A; Höhn A; Lâm TT; Frey A; Schubert-Unkmeir A; Dölken L; Frantz S; Kurzai O; Vogel U; Krone M; Petri N
J Med Virol; 2023 Jan; 95(1):e28300. PubMed ID: 36369641
[TBL] [Abstract][Full Text] [Related]
18. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff.
Martin CA; Patel P; Goss C; Jenkins DR; Price A; Barton L; Gupta P; Zaccardi F; Jerina H; Duraisingham S; Brunskill NJ; Khunti K; Pareek M
J Public Health (Oxf); 2022 Jun; 44(2):234-245. PubMed ID: 33200200
[TBL] [Abstract][Full Text] [Related]
19. Antibody response after two doses of homologous or heterologous SARS-CoV-2 vaccines in healthcare workers at health promotion centers: A prospective observational study.
Nah EH; Cho S; Park H; Kim S; Noh D; Kwon E; Cho HI
J Med Virol; 2022 Oct; 94(10):4719-4726. PubMed ID: 35655438
[TBL] [Abstract][Full Text] [Related]
20. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
Front Immunol; 2022; 13():827306. PubMed ID: 35173736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
